Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Friedberg

Showing results (61-70 of 300) with videos related to

Pageof 30
Sort By:
Blood|December 16, 2014
Transformed follicular non-Hodgkin lymphomaCarla Casulo, W Richard Burack, Jonathan W Friedberg
The New England Journal of Medicine|January 3, 2025
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma. ReplyAlex F Herrera, Michael LeBlanc, Jonathan W Friedberg
Ejhaem|November 29, 2023
Current directions in the treatment of classical Hodgkin lymphomaFrank G Keller, Brad Kahl, Jonathan W Friedberg
Lancet (London, England)|January 25, 2021
Classical Hodgkin lymphomaPauline Brice, Eric de Kerviler, Jonathan W Friedberg
Oncology (Williston Park, N.Y.)|April 3, 2007
Novel concepts in radioimmunotherapy for non-Hodgkin's lymphomaJulia Schaefer-Cutillo, Jonathan W Friedberg, Richard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2023
Flashback Foreword: Gemcitabine for Advanced Pancreatic CancerEileen M O'Reilly, Andrew H Ko, Jonathan W Friedberg
Clinical Advances in Hematology & Oncology : H&O|August 18, 2010
Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapyBrad S Kahl, Bruce D Cheson, Jonathan W Friedberg
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Accurate reporting of adverse events in chronic lymphocytic leukemia and non-Hodgkin lymphomaBruce D Cheson, Kanti R Rai, Jonathan W Friedberg
Best Practice & Research. Clinical Haematology|June 13, 2012
Novel agents in mantle cell lymphomaMarcus S Noel, Jonathan W Friedberg, Paul M Barr
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
A New Look as <i>JCO</i> Looks to the FutureKathy D Miller, Angela Cochran, Emilie Gunn, et al.
Pageof 30

Showing results (61-70 of 300) with videos related to

Sort By:
Pageof 30
Blood|December 16, 2014
Transformed follicular non-Hodgkin lymphomaCarla Casulo, W Richard Burack, Jonathan W Friedberg
The New England Journal of Medicine|January 3, 2025
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma. ReplyAlex F Herrera, Michael LeBlanc, Jonathan W Friedberg
Ejhaem|November 29, 2023
Current directions in the treatment of classical Hodgkin lymphomaFrank G Keller, Brad Kahl, Jonathan W Friedberg
Lancet (London, England)|January 25, 2021
Classical Hodgkin lymphomaPauline Brice, Eric de Kerviler, Jonathan W Friedberg
Oncology (Williston Park, N.Y.)|April 3, 2007
Novel concepts in radioimmunotherapy for non-Hodgkin's lymphomaJulia Schaefer-Cutillo, Jonathan W Friedberg, Richard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2023
Flashback Foreword: Gemcitabine for Advanced Pancreatic CancerEileen M O'Reilly, Andrew H Ko, Jonathan W Friedberg
Clinical Advances in Hematology & Oncology : H&O|August 18, 2010
Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapyBrad S Kahl, Bruce D Cheson, Jonathan W Friedberg
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Accurate reporting of adverse events in chronic lymphocytic leukemia and non-Hodgkin lymphomaBruce D Cheson, Kanti R Rai, Jonathan W Friedberg
Best Practice & Research. Clinical Haematology|June 13, 2012
Novel agents in mantle cell lymphomaMarcus S Noel, Jonathan W Friedberg, Paul M Barr
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
A New Look as <i>JCO</i> Looks to the FutureKathy D Miller, Angela Cochran, Emilie Gunn, et al.
Pageof 30